Skip to main content

MOORE CAPITAL MANAGEMENT, LP

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1448574 NEW YORK, NY

Position in TRDA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$772,800
-$552,300 QoQ
Shares Held
105,000
0.0% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#33
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRDA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names. TRDA ranks #28 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRDA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $772,800 105,000
2026-03-31 $1,325,100 105,000
2025-12-31 $1,079,400 105,000
2025-09-30 $609,000 105,000
2025-06-30 $705,600 105,000
2025-03-31 $949,200 105,000
2024-12-31 $1,815,450 105,000
2024-09-30 $1,677,900 105,000
2024-06-30 $1,496,250 105,000
2024-03-31 $1,487,850 105,000
2023-12-31 $1,584,450 105,000
2023-09-30 $1,659,000 105,000
2023-06-30 $1,589,700 105,000
2023-03-31 $1,522,500 105,000
2022-12-31 $1,419,600 105,000
2022-09-30 $1,654,800 105,000
2022-06-30 $1,278,900 105,000
2022-03-31 $985,950 105,000
2021-12-31 $1,797,600 105,000